We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment (TTX-CINP-201)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01655823
Recruitment Status : Terminated (Interim analysis completed and decided to terminate and proceed to Phase 3 trial.)
First Posted : August 2, 2012
Last Update Posted : June 3, 2015
Information provided by (Responsible Party):
Wex Pharmaceuticals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : January 2015
  Estimated Study Completion Date : December 2016